TrademarkOpen
Search / United States / 97207472

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Service Mark

S

Registered
Used for: Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene…
Show more

Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use

Class 42 – Technology & SaaS

Status timeline

  1. 11 Jan 2022
    Application filed
    New Application Entered
  2. 20 Jul 2022
    Assigned to an examining attorney
    Assigned To Examiner
  3. 25 Jul 2022
    Office action issued
    Non-Final Action Written
  4. 12 Dec 2022
    Response to office action filed
    Teas Response To Office Action Received
  5. 15 Dec 2022
    Approved for publication
    Approved For Pub - Principal Register
  6. 17 Jan 2023
    Published for opposition
    Published For Opposition
  7. 14 Mar 2023
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 14 Jul 2023
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 13 Mar 2024
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 9 Sep 2024
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
  11. 10 Mar 2025
    Statement of use filed
    Teas Statement Of Use Received
  12. 27 Jun 2025
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  13. 16 Jul 2025
    Statement of use accepted
    Notice Of Acceptance Of Statement Of Use E-Mailed
  14. 22 Jul 2025
    Registered on the Principal Register
    Registered-Principal Register
All 35 events
2025-07-22Registered-Principal Register
2025-07-22Notice Of Registration Confirmation Emailed
2025-07-16Notice Of Acceptance Of Statement Of Use E-Mailed
2025-06-27Allowed Principal Register - Sou Accepted
2025-06-03Case Assigned To Intent To Use Paralegal
2025-06-02Statement Of Use Processing Complete
2025-03-10Teas Statement Of Use Received
2025-03-09Use Amendment Filed
2024-09-09Sou Teas Extension Received
2024-09-09Sou Extension 3 Filed
2024-09-09Sou Extension 3 Granted
2024-09-09Notice Of Approval Of Extension Request E-Mailed
2024-03-14Notice Of Approval Of Extension Request E-Mailed
2024-03-13Sou Teas Extension Received
2024-03-13Sou Extension 2 Filed
2024-03-13Sou Extension 2 Granted
2023-07-18Notice Of Approval Of Extension Request E-Mailed
2023-07-14Sou Teas Extension Received
2023-07-14Sou Extension 1 Filed
2023-07-14Sou Extension 1 Granted
2023-03-14Noa Mailed - Sou Required From Applicant
2023-01-17Published For Opposition
2023-01-17Official Gazette Publication Confirmation E-Mailed
2022-12-28Notification Of Notice Of Publication E-Mailed
2022-12-15Approved For Pub - Principal Register
2022-12-13Teas/Email Correspondence Entered
2022-12-12Teas Response To Office Action Received
2022-12-12Correspondence Received In Law Office
2022-07-25Non-Final Action Written
2022-07-25Non-Final Action E-Mailed
2022-07-25Notification Of Non-Final Action E-Mailed
2022-07-20Assigned To Examiner
2022-01-14Notice Of Design Search Code E-Mailed
2022-01-13New Application Office Supplied Data Entered
2022-01-11New Application Entered

Goods & services by class

Class 42 Technology & SaaS

Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use

First use anywhere 1 Mar 2022 · First use in commerce 1 Mar 2022

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 22 Jul 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.